FDA Inspection
Chartwell Pharmaceuticals LLCChartwell Pharmaceuticals LLC – FDA Inspection, Apr 8, 2024
Record Details
This FDA Inspection record concerns Chartwell Pharmaceuticals LLC, with an inspection on April 8, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8d444b79-8c46-47c6-be01-f5119734136c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1230475
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 314.81(b)(2)Timely submission
- 21 CFR 314.80(c)(2)Late submission of annual safety reports
- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
- 21 CFR 314.80(c)(2)Interval
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Chartwell Pharmaceuticals LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2025 | OAI | New York District Office | Drug Quality Assurance |
| December 19, 2024 | Not classified | New York District Office | Drug Quality Assurance |
| May 31, 2024 | OAI | New York District Office | Generic Drug Evaluation |
| May 24, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chartwell Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.